Advertisement

Hereditary Angioedema

  • Saumya Maru
  • Timothy Craig
Living reference work entry

Abstract

Hereditary angioedema (HAE) is a rare disease affecting approximately 1 in 50,000 people and presents with recurrent cutaneous and mucosal membrane swelling. The result is recurrent angioedema, intermittent abdominal obstruction and pain, and airway swelling. Though death is rare in patients diagnosed and on therapy, upper airway swelling can be fatal. Disability and absenteeism secondary to the frequent attacks lasting up to 3 days can limit quality of life and education and occupational stability. Multiple therapies have been approved in the last decade and have made drastic improvements in this orphan disease. This chapter will discuss epidemiology, signs and symptoms, differential diagnosis, diagnosis, treatment, and management of the HAE patient.

Keywords

Hereditary angioedema (HAE) Angioedema Bradykinin C1 inhibitor (C1-INH) C1-esterase inhibitor 

References

  1. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71(4):206–15.CrossRefGoogle Scholar
  2. Betschel S, Badiou J, Binkley K, Hébert J, Kanani A, Keith P, et al. Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2014;10(1):50.  https://doi.org/10.1186/1710-1492-10-50.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Bonnaud I, Rouaud V, Guyot M, Debiais S, Saudeau D, de Toffol B, et al. Exceptional stroke-like episodes in a patient with type I autosomal angioedema. Neurology. 2012;78(8):598–9.  https://doi.org/10.1212/WNL.0b013e318247ca58.CrossRefPubMedGoogle Scholar
  4. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003a;114(4):294–8.CrossRefPubMedGoogle Scholar
  5. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003b;163(10):1229–35.  https://doi.org/10.1001/archinte.163.10.1229.CrossRefPubMedGoogle Scholar
  6. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267–74.  https://doi.org/10.1016/j.amjmed.2005.09.064.CrossRefPubMedGoogle Scholar
  7. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007a;119(6):1497–503.  https://doi.org/10.1016/j.jaci.2007.02.012.CrossRefPubMedGoogle Scholar
  8. Bork K, Gül D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med. 2007b;120(11):987–92.  https://doi.org/10.1016/j.amjmed.2007.08.021.CrossRefPubMedGoogle Scholar
  9. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692–7.  https://doi.org/10.1016/j.jaci.2012.05.055.CrossRefPubMedGoogle Scholar
  10. Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5):484.e1–4.  https://doi.org/10.1016/j.ajog.2008.04.034.CrossRefGoogle Scholar
  11. Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol. 2008;100(1 Suppl 2):S30–40.CrossRefPubMedGoogle Scholar
  12. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. 2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24.  https://doi.org/10.1186/1710-1492-6-24.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, et al. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J Allergy Clin Immunol. 1986;77(5):749–57.CrossRefPubMedGoogle Scholar
  14. Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol. 2012;129(2):308–20.  https://doi.org/10.1016/j.jaci.2011.11.025.CrossRefPubMedGoogle Scholar
  15. Cancian M, Vettore G, Realdi G. An uncommon cause of acute pancreatitis. Hereditary angioedema-induced acute pancreatitis. Gastroenterology. 2011;140(1):33, 370.  https://doi.org/10.1053/j.gastro.2010.02.064.CrossRefPubMedGoogle Scholar
  16. Chinniah N, Katelaris CH. Hereditary angioedema and pregnancy. Aust N Z J Obstet Gynaecol. 2009;49(1):2–5.  https://doi.org/10.1111/j.1479-828X.2008.00945.x.CrossRefPubMedGoogle Scholar
  17. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012;67(2):147–57.  https://doi.org/10.1111/j.1398-9995.2011.02751.x.CrossRefPubMedGoogle Scholar
  18. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014a;69(5):602–16.  https://doi.org/10.1111/all.12380.CrossRefPubMedGoogle Scholar
  19. Cicardi M, Bellis P, Bertazzoni G, Cancian M, Chiesa M, Cremonesi P, et al. Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med. 2014b;9(1):85–92.  https://doi.org/10.1007/s11739-013-0993-z.CrossRefPubMedGoogle Scholar
  20. Craig T, Aygören-Pürsün E, Bork K, Bowen T, Boysen H, Farkas H, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J. 2012;5(12):182–99.  https://doi.org/10.1097/WOX.0b013e318279affa.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009;15(2):69–78.  https://doi.org/10.1016/j.molmed.2008.12.001.CrossRefPubMedGoogle Scholar
  22. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286–9.  https://doi.org/10.1016/j.bbrc.2006.03.092.CrossRefPubMedGoogle Scholar
  23. Frémeaux-Bacchi V, Guinnepain MT, Cacoub P, Dragon-Durey MA, Mouthon L, Blouin J, et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med. 2002;113(3):194–9.CrossRefPubMedGoogle Scholar
  24. Gelfand JA, Boss GR, Conley CL, Reinhart R, Frank MM. Acquired C1 esterase inhibitor deficiency and angioedema: a review. Medicine (Baltimore). 1979;58(4):321–8.CrossRefGoogle Scholar
  25. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379–94.  https://doi.org/10.1111/j.1365-2249.2005.02726.x.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(3):193–204.  https://doi.org/10.1016/j.anai.2010.01.007.CrossRefPubMedGoogle Scholar
  27. Koide M, Shirahama S, Tokura Y, Takigawa M, Hayakawa M, Furukawa F. Lupus erythematosus associated with C1 inhibitor deficiency. J Dermatol. 2002;29(8):503–7.CrossRefPubMedGoogle Scholar
  28. Kusuma A, Relan A, Knulst AC, Moldovan D, Zuraw B, Cicardi M, et al. Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med. 2012;125(9):937.e17–24.  https://doi.org/10.1016/j.amjmed.2011.12.016.CrossRefGoogle Scholar
  29. Longhurst HJ, Tarzi MD, Ashworth F, Bethune C, Cale C, Dempster J, et al. C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clin Exp Immunol. 2015;180(3):475–83.  https://doi.org/10.1111/cei.12584.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31(5):407–14.  https://doi.org/10.2500/aap.2010.31.3394.CrossRefPubMedGoogle Scholar
  31. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Heller C, Klingebiel T, Kreuz W. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol. 2010;203(2):131.e1–7.  https://doi.org/10.1016/j.ajog.2010.03.003.CrossRefGoogle Scholar
  32. Matesic D, Fernández Pérez ER, Vlahakis NE, Hagan JB. Acute pancreatitis due to hereditary angioedema. Ann Allergy Asthma Immunol. 2006;97(5):611–4.CrossRefPubMedGoogle Scholar
  33. Nzeako UC, Longhurst HJ. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema. Eur J Gastroenterol Hepatol. 2012;24(4):353–61.  https://doi.org/10.1097/MEG.0b013e3283517998.CrossRefPubMedGoogle Scholar
  34. Ohsawa I, Nagamachi S, Suzuki H, Honda D, Sato N, Ohi H, et al. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. BMC Gastroenterol. 2013;13:123.  https://doi.org/10.1186/1471-230X-13-123.CrossRefPubMedPubMedCentralGoogle Scholar
  35. Palazzi C, D’Amico E, Cacciatore P, Pennese E, Olivieri I. Non-rheumatoid erosive arthritis associated with type I hereditary angioedema. Clin Rheumatol. 2005;24(6):632–3.  https://doi.org/10.1007/s10067-005-1097-6.CrossRefPubMedGoogle Scholar
  36. Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 2000;106(6):1147–54.  https://doi.org/10.1067/mai.2000.110471.CrossRefPubMedGoogle Scholar
  37. Prada AE, Zahedi K, Davis AE. Regulation of C1 inhibitor synthesis. Immunobiology. 1998;199(2):377–88.  https://doi.org/10.1016/S0171-2985(98)80042-9.CrossRefPubMedGoogle Scholar
  38. Reshef A, Prematta MJ, Craig TJ. Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys. Allergy Asthma Proc. 2013;34(3):261–6.  https://doi.org/10.2500/aap.2013.34.3663.CrossRefPubMedGoogle Scholar
  39. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, López-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005;94(4):498–503.  https://doi.org/10.1016/S1081-1206(10)61121-0.CrossRefPubMedGoogle Scholar
  40. Tarzi MD, Hickey A, Förster T, Mohammadi M, Longhurst HJ. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clin Exp Immunol. 2007;149(3):513–6.  https://doi.org/10.1111/j.1365-2249.2007.03438.x.CrossRefPubMedPubMedCentralGoogle Scholar
  41. Tosi M. Molecular genetics of C1 inhibitor. Immunobiology. 1998;199(2):358–65.  https://doi.org/10.1016/S0171-2985(98)80040-5.CrossRefPubMedGoogle Scholar
  42. Wahn V, Aberer W, Eberl W, Faßhauer M, Kühne T, Kurnik K, et al. Hereditary angioedema (HAE) in children and adolescents – a consensus on therapeutic strategies. Eur J Pediatr. 2012;171(9):1339–48.  https://doi.org/10.1007/s00431-012-1726-4.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M, et al. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis. 2015;10:11.  https://doi.org/10.1186/s13023-015-0233-x.CrossRefPubMedPubMedCentralGoogle Scholar
  44. Zuraw BL, Sugimoto S, Curd JG. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. J Allergy Clin Immunol. 1986;78(6):1115–20.CrossRefPubMedGoogle Scholar
  45. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, et al. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012;33(Suppl 1):S145–56.  https://doi.org/10.2500/aap.2012.33.3627.CrossRefPubMedGoogle Scholar
  46. Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, et al. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013;1(5):458–67.  https://doi.org/10.1016/j.jaip.2013.07.002.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Penn State College of MedicineHersheyUSA
  2. 2.Department of Medicine and PediatricsPenn State College of MedicineHersheyUSA

Section editors and affiliations

  • Tim Craig
    • 1
  • Massoud Mahmoudi
    • 2
  1. 1.Penn State UniversityHersheyUSA
  2. 2.Department of MedicineUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations